Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |